SCONE™ clinical trials
SCONE™ is an investigational device. The purpose of the SCONE™ clinical trial is to study the effectiveness and safety of neuromodulation therapy for individuals with neurogenic bladder due to stroke, spinal cord injury, or multiple sclerosis.
You can find a list of clinical trial sites below and full details about the inclusion and exclusion criteria here. If you are interested in participating or would like more information, please contact the primary coordinator at your nearest site or email info@spinex.co.
The SCONE™ study is actively recruiting at multiple sites across the US and globally
United States
| Institution | Principal Investigator | Primary Coordinator |
|---|---|---|
|
Rancho Rsearch (Downey, CA) |
Nina Patel, MD |
Scott Igtanloc scotti@ranchoresearch.org |
|
MedStar (Washington, DC) |
Suzanne Groah, MD |
Christopher Reigner christopher.r.reigner@medstar.net |
|
Craig Hospital (Denver, CO) |
Candy Tefertiller, PhD |
Claire Morey cmorey@craighospital.org |
|
UC San Diego (San Diego, CA) |
Yahir Santiago-Lastra, MD |
Trisha Kanie tkanie@health.ucsd.edu |
|
Atrium Health (Charlotte, NC) |
Michael Kennelly, MD |
Robbin Clark robbin.Clark@atriumhealth.org |
|
Columbia University (New York, NY) |
Doreen Chung, MD |
Nurshath Kalam nk3119@cumc.columbia.edu |
|
University of Miami (Miami, FL) |
Raveen Syan, MD |
Zoe Szczotka zxs537@miami.edu |
|
Mayo Clinic (Rochester, MN) |
Kristin Zhao, PhD |
Tyson Scrabeck scrabeck.tyson@mayo.edu |
|
Harvard (Cambridge, MA) |
Randy Trumbower, MD |
William Muter wmuter@mgb.org |
|
Shepherd Clinic (Atlanta, GA) |
Rita Jen, MD |
Cathy Furbish cathy.furbish@shepherd.org |
Canada
| Institution | Principal Investigator | Primary Coordinator |
|---|---|---|
|
ICORD (Vancouver, BC) |
Andrei Krassioskov, MD, PhD |
Jennifer Phan anhduong.phan@ubc.ca |
India
| Institution | Principal Investigator | Primary Coordinator |
|---|---|---|
|
Institute of Brain and Spine (New Delhi, India) |
Sachin Kandhari, MD |
Surbhi Kaura physiosurbhi123@gmail.com |